Aura Biosciences, Inc.

NASDAQ:AURA

5.47 (USD) • At close May 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -25.834-21.042-20.337-19.706-22.131-18.512-18.299-17.466-16.559-15.901-13.468-12.835-11.634-8.838-8.852-5.927-4.907-3.631-6.156-7.512
Depreciation & Amortization 0.2910.3130.3130.3060.3240.3430.30.3280.3230.3020.2960.2560.230.2160.20.1850.2260.2320.1910.182
Deferred Income Tax 0000-2.794-0.82-1.0280000024.109-0.0520.052-0.0040000
Stock Based Compensation 2.9372.753.1262.9092.6032.3251.9311.9131.8141.7171.2871.5941.2970.5540.2710.1850.1790.1910.1890.177
Change In Working Capital -0.9423.3781.725-6.8032.0340.8081.894-0.295-3.773.4631.455-4.25-1.997-0.5721.8260.4280.748-3.405-0.683-1.603
Accounts Receivables 00000000000000000000
Change In Inventory 00000000000000000000
Change In Accounts Payables 0.310.689-0.540.0230.4570.885-0.501-1.8811.0180.837-0.759-0.7560.163-0.7210.9120.70.116-3.10100
Other Working Capital -1.2522.6892.265-6.8261.577-0.0772.3951.881-4.7882.6261.906-3.494-2.160.1490.914-0.2720.632-0.304-0.683-1.603
Other Non Cash Items -0.404-0.672-0.9552.342.5770.4530.557-0.8920.179-0.3410.0050.035-24.0910.0020.006-0.004-0.0030.0010.5950.668
Operating Cash Flow -23.952-15.273-16.128-24.452-17.387-15.403-14.645-16.412-18.013-10.76-10.628-15.2-12.086-8.69-6.497-5.137-3.757-6.612-5.864-8.088
Investing Activities:
Investments In Property Plant And Equipment -0.299-0.341-0.525-0.088-0.317-0.09-0.193-0.109-0.358-0.063-0.074-0.599-0.819-0.573-0.662-0.071-0.132-0.101-0.06-0.478
Acquisitions Net 00000.09000.0670.01700000000000
Purchases Of Investments -0.005-19.998-9.904-29.201-144.80400-88.847-48.5180-46.367-24.89900000000
Sales Maturities Of Investments 29.99930.22830.2738.68555.00121.71921.622.0773218.0093000000000
Other Investing Activites 0009.484-0.090.0220.022-0.067-0.0170.018-43.367-24.89900000000
Investing Cash Flow 29.6959.88919.8419.396-90.1221.62921.407-66.879-16.87617.946-43.441-25.498-0.819-0.573-0.662-0.071-0.132-0.101-0.06-0.478
Financing Activities:
Debt Repayment 00000000000000000000
Common Stock Issued 0-0.3360.0830.25392.9851.3522.4780.14500.1040.3090.01778.697-1.116-0.26587.4980000
Common Stock Repurchased 00000000000000000000
Dividends Paid 00000000000000000000
Other Financing Activities 0.5430.7160.0830.25392.9850.2742.4780.20195.1990.1040.3090.01780.142-1.116-0.26187.4895.1334.7990.0850.019
Financing Cash Flow 0.5430.7160.0830.25392.9851.6262.4780.20195.1990.1040.3090.01780.142-1.116-0.25687.4895.1334.7990.0850.019
Other Information:
Effect Of Forex Changes On Cash 000000000000-74.8660000000
Net Change In Cash 6.286-4.6683.796-14.803-14.5227.8529.24-83.0960.317.29-53.76-40.68167.237-10.379-7.41582.2811.244-1.914-5.839-8.547
Cash At End Of Period 32.46126.17530.07526.27941.08256.37248.5239.28122.3762.0654.77108.53149.21181.97492.35399.76817.48716.24318.15723.996